MX908

Product

Last mentioned: Mar 4, 2026

Stories mentioning MX908 2

pharma Neutral

908 Devices and Strata Critical Medical Signal Growth in Bioprocessing Tech

908 Devices and Strata Critical Medical reported Q4 2025 results, highlighting a surge in demand for decentralized analytical tools and critical care monitoring. Both companies are pivoting toward high-growth biopharma applications as they enter the 2026 fiscal year.

Mar 4, 2026 2 sources

medical-devices Neutral

MedTech's Shift to Recurring Revenue: 908 Devices and Strata Q4 Analysis

908 Devices and Strata Critical Medical reported Q4 2025 results highlighting a strategic pivot toward high-margin consumables and expanded clinical utility. As both firms navigate the post-pandemic capital equipment landscape, their focus on point-of-need diagnostics and regenerative therapies is driving a transition toward more predictable, recurring revenue streams.

Mar 4, 2026 2 sources